MTNB

AMEX Matinas BioPharma Holdings, Inc.
Oct 13, 2026 · 7:27 AM ET LAST TRADE Market Closed

$2.66 ↓ -0.08 (-2.81%) Trading Down from the previous close of $2.74

YTD change
-69.70%
vs 20-day SMA
+0.98%
vs 200-day SMA
-64.69%

Price ranges

Previous day
$2.70 $2.85
open $2.85 close $2.74
-$0.11 (-3.86%)
Today
$0.00 $0.00
$2.66
Past week
$2.61 $3.15
from $2.82 now $2.66
-$0.16 (-5.56%)
Past month
$2.26 $3.15
from $2.88 now $2.66
-$0.22 (-7.53%)
This year
$0.15 $8.79
from $8.79 now $2.66
-$6.13 (-69.70%)

Price & Performance

+2.24 (+444.73%) / 6M

$-0.0680$1.03$2.14$3.24Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.9% away from all-time highs of $2,992.50
  • MTNB is down 70% since the beginning of the year
  • MTNB is down 90% over the past 12 months
  • MTNB is down 8% over the past 1 month
  • 7% of all MTNB investors are betting against MTNB
  • Number of investors short MTNB has gone up 171% versus last month

MTNB reads poor: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is +49.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-3.1048
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $365.2K
Beta 2.86

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$811.0K
Debt$6.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeAMEX
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.6M

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $417.57 +0.65%
MRNA Moderna, Inc. $213.74 -5.00%
RVMD Revolution Medicines, Inc. $193.95 +2.21%
ROIV Roivant Sciences Ltd. $34.59 -2.40%
BNTX BioNTech SE Sponsored ADR $95.84 -1.16%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.